ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)

CUSIP: 00653A107

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / American Depositary Shares, each representing 6 Ordinary Shares
Shares outstanding
1,571,428,571
Total 13F shares
20,950,250
Share change
+20,471,396
Total reported value
$384,020,000
Price per share
$18.33
Number of holders
45
Value change
+$375,243,000
Number of buys
44

Quarterly Holders Quick Answers

What is CUSIP 00653A107?
CUSIP 00653A107 identifies ADAPY - ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY) as of Q2 2015

As of 30 Jun 2015, ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,950,250 shares. The largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, Novo A/S, Foresite Capital Management II, LLC, Capital World Investors, Partner Fund Management, L.P., Rock Springs Capital Management LP, ARROWGRASS CAPITAL PARTNERS (US) LP, JENNISON ASSOCIATES LLC, and QVT Financial LP. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.